ArticleFrontiers in neuroscience2025
Modeling and validation in Parkinson's disease patients with frailty.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive Risk Models for Frailty Onset in Older Adults: A Scoping Review of Methodological Trends, Model Performance, and Clinical Translation Gap.Clinical interventions in aging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's disease (PD) is the second most common neurodegenerative disorder. The risk of frailty is significantly higher in patients with PD than in age-matched individuals without PD. This study aimed to develop a machine learning-based predictive model for frailty in PD. Methods: We conducted a cross-sectional study of early- and middle-stage PD patients recruited from June 2024 to June 2025 at Shenzhen People's Hospital. Frailty was assessed using the Fried criteria (five components: gait speed, grip strength, physical activity, fatigue, and weight loss). A total of 42 demographic and clinical variables, including disease history, Montreal cognitive assessment (MoCA), and unified Parkinson's disease rating scale (MDS-UPDRS) scores, were collected and compared between PD patients with and without frailty. Spearman correlation and LASSO regression were used to identify independent risk factors. Multiple machine learning algorithms were applied to construct predictive models. Model performance was evaluated using receiver operating characteristic (ROC) curves, area under the ROC curve (AUC), decision curve analysis (DCA), calibration plots, and forest plots. Results: A total of 205 PD patients were enrolled (133 non-frail, 72 frail; mean age non-frail 62.92 ± 9.69 years, frail 68.13 ± 8.44 years). Significant group differences were found in sex ( Conclusion: Frailty in PD was associated with female sex, older age, alcohol use, and more advanced disease severity. Patients with PD and frailty exhibited higher MDS-UPDRS scores, more severe cognitive impairment, and greater levels of depression and anxiety. Integrating clinical data with machine learning, especially logistic regression, provides a reliable and scalable tool for early identification and risk stratification of frailty in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.